Payment overview · 2025
General Payments
$12,014.66
122 reported records · 28 companies
Healthcare provider profile · identity verified
Brandon Alan Diaz, MD
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · MIAMI, FL · NPI 1740631571
Verified facts
What the public records show
CMS Open Payments records show Brandon Alan Diaz, MD received $12,014.66 in general payments during 2025 across 122 reported records.
Medtronic, Inc. accounted for 32.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 53 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$3,936.99 | 32.8% | 30 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $2,472.84 | 20.6% | 12 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $954.08 | 7.9% | 8 | 2025 |
| ASAHI INTECC USA, INC. | Unresolved — no canonical attribution shown | $883.93 | 7.4% | 15 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $476.56 | 4.0% | 5 | 2025 |
| CARDIVA MEDICAL, INC. | Unresolved — no canonical attribution shown | $460.87 | 3.8% | 10 | 2025 |
| AtriCure, Inc. | Unresolved — no canonical attribution shown | $382.86 | 3.2% | 3 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $337.20 | 2.8% | 6 | 2025 |
| AXOGEN | Unresolved — no canonical attribution shown | $316.24 | 2.6% | 3 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $313.04 | 2.6% | 4 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $229.58 | 1.9% | 2 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $171.30 | 1.4% | 2 | 2025 |
| Access Pro Medical, LLC | Unresolved — no canonical attribution shown | $166.23 | 1.4% | 2 | 2025 |
| Medical Device Business Services, Inc. | Unresolved — no canonical attribution shown | $137.01 | 1.1% | 1 | 2025 |
| Davol Inc. | Unresolved — no canonical attribution shown | $131.57 | 1.1% | 1 | 2025 |
| TELA Bio, Inc. | Unresolved — no canonical attribution shown | $129.89 | 1.1% | 1 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $126.94 | 1.1% | 3 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $73.33 | 0.6% | 1 | 2025 |
| PolyNovo North America LLC | Unresolved — no canonical attribution shown | $54.60 | 0.5% | 1 | 2025 |
| Surmodics, Inc. | Unresolved — no canonical attribution shown | $49.00 | 0.4% | 3 | 2025 |
| Humacyte Global, Inc. | Unresolved — no canonical attribution shown | $37.45 | 0.3% | 1 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $35.68 | 0.3% | 2 | 2025 |
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $31.29 | 0.3% | 1 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $25.96 | 0.2% | 1 | 2025 |
| BIOTISSUE HOLDINGS INC. | Unresolved — no canonical attribution shown | $23.78 | 0.2% | 1 | 2025 |
| E.R. Squibb & Sons, L.L.C. | Unresolved — no canonical attribution shown | $21.68 | 0.2% | 1 | 2025 |
| Globus Medical, Inc. | Unresolved — no canonical attribution shown | $20.00 | 0.2% | 1 | 2025 |
| KLS-Martin L.P. | Unresolved — no canonical attribution shown | $14.76 | 0.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $9,191.35 | 115 |
| Grant | $1,500.00 | 1 |
| Travel and Lodging | $1,186.30 | 5 |
| Education | $137.01 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $1,829.79 | 8 | 2025 |
Source payment records
|
|||||
| Asahi Peripheral Vascular Wires Normalized: asahi peripheral vascular wires |
Device | ASAHI INTECC USA, INC. | $883.93 | 15 | 2025 |
Source payment records
|
|||||
| ENDURANT IIS Normalized: endurant iis |
Device | Medtronic, Inc. | $867.98 | 14 | 2025 |
Source payment records
|
|||||
| VALIANT CAPTIVIA Normalized: valiant captivia |
Device | Medtronic, Inc. | $675.08 | 5 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Neuroprotection System Normalized: enroute transcarotid neuroprotection system |
Device | Boston Scientific Corporation | $600.41 | 4 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $505.17 | 3 | 2025 |
Source payment records
|
|||||
| RotarexS 6 F x 135 cm Normalized: rotarexs 6 f x 135 cm |
Device | Bard Peripheral Vascular, Inc. | $449.80 | 4 | 2025 |
Source payment records
|
|||||
| PROTEGE RX Normalized: protege rx |
Device | Medtronic, Inc. | $352.42 | 4 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $332.21 | 5 | 2025 |
Source payment records
|
|||||
| HELI-FX ENDOANCHOR SYSTEM Normalized: heli fx endoanchor system |
Device | Medtronic, Inc. | $289.11 | 2 | 2025 |
Source payment records
|
|||||
| CARDIVA VASCADE MVP VVCS 6-12F Normalized: cardiva vascade mvp vvcs 6 12f |
Device | CARDIVA MEDICAL, INC. | $247.01 | 2 | 2025 |
Source payment records
|
|||||
| ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM Normalized: atricure cryoice cryosphere cryoablation system |
Device | AtriCure, Inc. | $218.76 | 2 | 2025 |
Source payment records
|
|||||
| CARDIVA VASCADE 6/7F VCS Normalized: cardiva vascade 6 7f vcs |
Device | CARDIVA MEDICAL, INC. | $201.94 | 7 | 2025 |
Source payment records
|
|||||
| Labosys Normalized: labosys |
Device | Philips North America LLC | $198.74 | 3 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Stryker Corporation | $192.74 | 1 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Stryker Corporation | $192.74 | 1 | 2025 |
Source payment records
|
|||||
| COLLAGENASE SANTYL Normalized: collagenase santyl |
Drug | Smith+Nephew, Inc. | $171.30 | 2 | 2025 |
Source payment records
|
|||||
| MATRIDERM Normalized: matriderm |
Device | Access Pro Medical, LLC | $166.23 | 2 | 2025 |
Source payment records
|
|||||
| EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX Normalized: epi sense guided coagulation system with visitrax |
Device | AtriCure, Inc. | $164.10 | 1 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Stent Normalized: enroute transcarotid stent |
Device | Boston Scientific Corporation | $149.20 | 1 | 2025 |
Source payment records
|
|||||
| POD Normalized: pod |
Device | Penumbra, Inc. | $137.88 | 1 | 2025 |
Source payment records
|
|||||
| STRATAFIX Normalized: stratafix |
Device | Medical Device Business Services, Inc. | $137.01 | 1 | 2025 |
Source payment records
|
|||||
| Ranger Normalized: ranger |
Device | Boston Scientific Corporation | $133.98 | 1 | 2025 |
Source payment records
|
|||||
| Phasix Mesh Normalized: phasix mesh |
Device | Davol Inc. | $131.57 | 1 | 2025 |
Source payment records
|
|||||
| OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) Normalized: ovitex reinforced bioscaffold with permanent polymer ovitex |
Device | TELA Bio, Inc. | $129.89 | 1 | 2025 |
Source payment records
|
|||||
| VENASEAL Normalized: venaseal |
Device | Medtronic, Inc. | $126.41 | 3 | 2025 |
Source payment records
|
|||||
| HAWKONE Normalized: hawkone |
Device | Medtronic, Inc. | $125.99 | 1 | 2025 |
Source payment records
|
|||||
| OASIS Normalized: oasis |
Device | Smith+Nephew, Inc. | $124.80 | 1 | 2025 |
Source payment records
|
|||||
| Versajet Normalized: versajet |
Device | Smith+Nephew, Inc. | $124.80 | 1 | 2025 |
Source payment records
|
|||||
| IV Other Normalized: iv other |
Device | Philips North America LLC | $114.30 | 1 | 2025 |
Source payment records
|
|||||
| PRODIGY CATHETER Normalized: prodigy catheter |
Device | Imperative Care, Inc | $87.75 | 2 | 2025 |
Source payment records
|
|||||
| PERCLOSE PROSTYLE Normalized: perclose prostyle |
Device | Abbott Laboratories | $73.33 | 1 | 2025 |
Source payment records
|
|||||
| ENHANCE Transcarotid Peripheral Access Kit Normalized: enhance transcarotid peripheral access kit |
Device | Boston Scientific Corporation | $70.49 | 2 | 2025 |
Source payment records
|
|||||
| NOVOSORB BTM Normalized: novosorb btm |
Device | PolyNovo North America LLC | $54.60 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy Normalized: pounce thrombectomy |
Device | Surmodics, Inc. | $49.00 | 3 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy System Normalized: pounce thrombectomy system |
Device | Surmodics, Inc. | $49.00 | 3 | 2025 |
Source payment records
|
|||||
| Pounce Venous Thrombectomy System Normalized: pounce venous thrombectomy system |
Device | Surmodics, Inc. | $49.00 | 3 | 2025 |
Source payment records
|
|||||
| HOTSHOT CONTROLLER Normalized: hotshot controller |
Device | Imperative Care, Inc | $39.19 | 1 | 2025 |
Source payment records
|
|||||
| Symvess Normalized: symvess |
Biological | Humacyte Global, Inc. | $37.45 | 1 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER Normalized: flowtriever |
Device | Stryker Corporation | $36.84 | 1 | 2025 |
Source payment records
|
|||||
| LEQVIO Normalized: leqvio |
Drug | Novartis Pharmaceuticals Corporation | $31.29 | 1 | 2025 |
Source payment records
|
|||||
| Pounce LP Thrombectomy Normalized: pounce lp thrombectomy |
Device | Surmodics, Inc. | $28.47 | 2 | 2025 |
Source payment records
|
|||||
| Pounce XL Thrombectomy Normalized: pounce xl thrombectomy |
Device | Surmodics, Inc. | $28.47 | 2 | 2025 |
Source payment records
|
|||||
| Venclose Maven Catheter Normalized: venclose maven catheter |
Device | Bard Peripheral Vascular, Inc. | $26.76 | 1 | 2025 |
Source payment records
|
|||||
| AZUR CX DETACHABLE Normalized: azur cx detachable |
Device | Terumo Medical Corporation | $25.96 | 1 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | E.R. Squibb & Sons, L.L.C. | $21.68 | 1 | 2025 |
Source payment records
|
|||||
| AURYON LASER SYSTEM 100-120 VAC Normalized: auryon laser system 100 120 vac |
Device | AngioDynamics, Inc. | $21.10 | 1 | 2025 |
Source payment records
|
|||||
| Sublime 014 Rx PTA Balloon Dilatation Catheter Normalized: sublime 014 rx pta balloon dilatation catheter |
Device | Surmodics, Inc. | $20.53 | 1 | 2025 |
Source payment records
|
|||||
| Sublime Microcatheter, 018, 200cm, Straight Normalized: sublime microcatheter 018 200cm straight |
Device | Surmodics, Inc. | $20.53 | 1 | 2025 |
Source payment records
|
|||||
| ALIF Normalized: alif |
Device | Globus Medical, Inc. | $20.00 | 1 | 2025 |
Source payment records
|
|||||
| ANGIODYNAMICS Normalized: angiodynamics |
Device | AngioDynamics, Inc. | $14.58 | 1 | 2025 |
Source payment records
|
|||||
| CARDIVA VASCADE 5F VCS Normalized: cardiva vascade 5f vcs |
Device | CARDIVA MEDICAL, INC. | $11.92 | 1 | 2025 |
Source payment records
|
|||||
| AMPLATZ Normalized: amplatz |
Device | Cook Medical LLC | $4.99 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $12,014.66 · 122 records | Medtronic, Inc. | ALIF, AMPLATZ, ANGIODYNAMICS, ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, AURYON LASER SYSTEM 100-120 VAC, AZUR CX DETACHABLE, Asahi Peripheral Vascular Wires, CARDIVA VASCADE 5F VCS, CARDIVA VASCADE 6/7F VCS, CARDIVA VASCADE MVP VVCS 6-12F, COLLAGENASE SANTYL, CT THROMBECTOMY SYSTEM KIT, ELIQUIS, ENDURANT IIS, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, FLOWTRIEVER, FLOWTRIEVER CATHETER, S, HAWKONE, HELI-FX ENDOANCHOR SYSTEM, HOTSHOT CONTROLLER, IV Other, Indigo System, LEQVIO, Labosys, MATRIDERM, NOVOSORB BTM, OASIS, OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex), PERCLOSE PROSTYLE, POD, PRODIGY CATHETER, PROTEGE RX, Penumbra System, Phasix Mesh, Pounce LP Thrombectomy, Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce XL Thrombectomy, Ranger, RotarexS 6 F x 135 cm, STRATAFIX, Sublime 014 Rx PTA Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight, Symvess, VALIANT CAPTIVIA, VENASEAL, Venclose Maven Catheter, Versajet, ZILVER PTX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error